Aurinia Pharmaceuticals Inc (AUPH) is a publicly traded Healthcare sector company. As of November 16, 2026, AUPH trades at $15.48 with a market cap of $2.11B and a P/E ratio of 6.75. AUPH moved -1.59% today. Year to date, AUPH is +0.81%; over the trailing twelve months it is +0.81%. Its 52-week range spans $6.83 to $19.25. Analyst consensus is buy with an average price target of $19.00. Rallies surfaces AUPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AUPH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AUPH recently traded at $15.48. Market cap is $2.11B. P/E ratio is 6.75. Revenue is $311.51M.
| Metric | Value |
|---|---|
| Price | $15.48 |
| Market Cap | $2.11B |
| P/E Ratio | 6.75 |
| EPS | $2.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.25 |
| 52-Week Low | $6.83 |
| Volume | 748.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $311.51M |
| Net Income | $314.11M |
| Gross Margin | 90.36% |
3 analysts cover AUPH: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.00.